Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Anthony T. Lo Sasso - What's Behind Pharma's Attack On Hospitals? Understanding The 340B Program
What's Behind Pharma's Attack On Hospitals? Understanding The 340B Program
Forbes

Outpatient hospital infusion services are one of the settings where drugs may be purchased at discounted 340B prices and reimbursed at standard rates. If you've watched cable news recently, you may have seen a PhRMA commercial. In it, we are…

seekingalpha.com - Gen Alpha - Merck: Buy The Dip On This Dividend Growth Pharma Leader (NYSE:MRK)
Merck: Buy The Dip On This Dividend Growth Pharma Leader (NYSE:MRK)
Seeking Alpha

Merck is a buy-the-dip opportunity after a pullback to $114.90, offering a compelling entry for value and income investors. MRK's robust pipeline, including 20 potential blockbusters and strategic acquisitions like Terns, positions it to bridge the…

cnbc.com - Elsa Ohlen - Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
CNBC

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track process: preparing for an IPO while…

express.co.uk - Ewan Gleadow - Boots takeover in crisis as pharma giant pulls out of £7bn deal
Boots takeover in crisis as pharma giant pulls out of £7bn deal
Daily Express

A multi-billion pound takeover of Boots has been scrapped (file) A proposed £7billion takeover of Boots has been scrapped by the pharmaceutical giant which put the bid in. Sigma Healthcare, the Australian pharmaceutical wholesaler and…

seekingalpha.com - Arundhati Sarkar - JPMorgan bankers say Big Pharma M&A still outpaces biotech IPOs: report (IBB:NASDAQ)
JPMorgan bankers say Big Pharma M&A still outpaces biotech IPOs: report (IBB:NASDAQ)
Seeking Alpha

Investors are more selective post-pandemic, and Big Pharma is aggressively acquiring to boost pipelines, making sellouts more appealing for top biotech firms than IPOs. Big Pharma is funded and willing to pay more for priority assets, increasing…

axios.com - Zachery Eanes - Raleigh agtech company Targan has been bought by pharma giant Merck
Raleigh agtech company Targan has been bought by pharma giant Merck
Axios

Pharmaceutical giant Merck is acquiring a Raleigh company whose technology helps poultry producers identify the sex of chicks and vaccinate them. Why it matters: Merck's acquisition of Targan, whose labs are located in a redeveloped Kroger on Six…

thehindubusinessline.com - Armenia healthcare scheme opens oncology drug export opportunities for Indian pharma companies
Armenia healthcare scheme opens oncology drug export opportunities for Indian pharma companies
BusinessLine

A new scheme launched by the Republic of Armenia in the healthcare sector has opened up export opportunities for Indian pharma companies in the oncology space. According to Raj Bhanu, Director-General of the Pharmaceutical Export Promotion Council…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Given New $96.00 Price Target at Mizuho
BridgeBio Pharma (NASDAQ:BBIO) Given New $96.00 Price Target at Mizuho
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price reduced by Mizuho from $106.00 to $96.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm presently has an 'outperform' rating on the stock. Mizuho's…

swissinfo.ch - swissinfo.ch - Swiss paediatricians adopt new growth charts for more precise monitoring
Swiss paediatricians adopt new growth charts for more precise monitoring
www.swissinfo.ch

The new recommendations are based on one of the largest development studies in Europe, the Paediatric Endocrinology Centre Zurich explained on Tuesday. The study analysed data from over 43,000 children and adolescents from all linguistic regions of…

marketbeat.com - 2,750,000 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by Brooklands Fund Management Ltd
2,750,000 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by Brooklands Fund Management Ltd
MarketBeat

Brooklands Fund Management Ltd bought a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought…

marketbeat.com - L2 Asset Management LLC Has $5.63 Million Stock Position in Royalty Pharma PLC $RPRX
L2 Asset Management LLC Has $5.63 Million Stock Position in Royalty Pharma PLC $RPRX
MarketBeat

L2 Asset Management LLC increased its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 58.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The…

marketbeat.com - Sofinnova Investments Inc. Sells 111,399 Shares of BridgeBio Pharma, Inc. $BBIO
Sofinnova Investments Inc. Sells 111,399 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Sofinnova Investments Inc. decreased its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 13.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund…

marketbeat.com - Arrowstreet Capital Limited Partnership Acquires 31,091 Shares of Royalty Pharma PLC $RPRX
Arrowstreet Capital Limited Partnership Acquires 31,091 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Arrowstreet Capital Limited Partnership boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.

globenewswire.com - Orion Oyj - Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire

STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…

channelnewsasia.com - AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
CNA

BUDAPEST, June 16: Increased deployment of AI could unlock €15 billion ($17.42 billion) in productivity gains in Hungary by 2030, McKinsey said on Tuesday. AI could help Hungary close some of its productivity gap with European neighbours…

Receive a Daily briefing on Pharma Industry News

Get Started